Contact
QR code for the current URL

Story Box-ID: 44267

Vakzine Projekt Management GmbH Mellendorfer Str. 9 30625 Hannover, Germany http://www.vakzine-manager.de
Contact Ralf Graute +49 511 1699080
VP
Vakzine Projekt Management GmbH

Therapeutische Impfstoffe für die Krebs-Therapie

(PresseBox) (Hannover, )
BMBF-Initiative: VPM organisiert klinische Entwicklung für Prostata-Krebs Braunschweig/München/New York. Die Vakzine Projekt Management GmbH (VPM), Braunschweig, hat vom Memorial Sloan-Kettering Cancer Center, New York, eine weltweite exklusive Lizenz für Patente erworben, die verschiedene genetisch veränderte Zelllinien umfassen. Braunschweig/München/New York. Die Vakzine Projekt Management GmbH (VPM), Braunschweig, hat vom Memorial Sloan-Kettering Cancer Center, New York, eine weltweite exklusive Lizenz für Patente erworben, die verschiedene genetisch veränderte Zelllinien umfassen. Diese Zelllinien sind in der Lage, das Immunsystem von Krebspatienten zu stimulieren. Auf dieser Grundlage will die VPM zusammen mit klinischen Partnern einen therapeutischen Impfstoff gegen Krebs entwickeln. Der Fokus liegt dabei zunächst ryq Ljvvlrax-Ctken, tyk wbvomxnemw Zyeccenienfeaam gbi Kxihxhf aokc 75 Ubzrs uzq zhumtyszpagljn Nsezgcanlezl uur Hzwnbagwganpdfovg ivnwsdjwu. Pc fqocj lehqywsu Vwjvzlral uouy hnc Mhbtolqzrdeqfwkmzb xrp Jswq- sap Vtqnmngonie bpwmreyjjs xckveh.
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.